The emergence of SARS-CoV-2 variants that are more resistant to antibody-mediated
neutralization pose a new hurdle in combating the COVID-19 pandemic. Although vaccines …

Memory B cells (MBCs) generate rapid antibody responses upon secondary encounter with
a pathogen. Here, we investigated the kinetics, avidity, and cross-reactivity of serum …

Global health challenges such as the coronavirus pandemic warrant the urgent need for a
system that allows efficient production of diagnostic and therapeutic interventions. Antibody …

The interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the ACE2
receptor on host cells is essential for viral entry. RBD is the dominant target for neutralizing …

Drug repositioning continues to be the most effective, practicable possibility to treat COVID-
19 patients. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus …

The COVID-19 pandemic has become a global health crisis, inflicting substantial morbidity
and mortality worldwide. A diverse range of symptoms, including fever, cough, dyspnea, and …

T cells play a crucial role in combatting SARS-CoV-2 and forming long-term memory
responses to this coronavirus. The emergence of SARS-CoV-2 variants that can evade T cell …

The severe acute respiratory syndrome virus-2 (SARS CoV-2) infection has resulted in the
current global pandemic. The binding of SARS CoV-2 spike protein receptor-binding domain …

Background The COVID‐19 pandemic has created unprecedented challenges in all fields of
society with social, economic, and health‐related consequences worldwide. In this context …

SARS-CoV-2 infects humans and causes Coronavirus disease 2019 (COVID-19). The S1
domain of the spike glycoprotein of SARS-CoV-2 binds to human angiotensin-converting …